SynopsisH
Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials
Eric Wooltorton
CMAJ April 27, 2004 170 (9) 1395; DOI: https://doi.org/10.1503/cmaj.1040539
Article Figures & Tables
Tables
In this issue
Article tools
Respond to this article
Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials
Eric Wooltorton
CMAJ Apr 2004, 170 (9) 1395; DOI: 10.1503/cmaj.1040539
Jump to section
Related Articles
Cited By...
- Risk of incident stroke in patients with Alzheimer disease or vascular dementia
- Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study
- Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease
- Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis
- Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning.
- Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications
- Increased mortality among elderly patients with dementia using atypical antipsychotics
- Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study